__NUXT_JSONP__("/drugs/Trabedersen", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"925681-61-4",chebiId:b,chemicalFormula:b,definition:"A transforming growth factor (TGF)-beta2 specific phosphorothioate antisense oligodeoxynucleotide with the sequence 5'-CGGCATGTCTATTTTGTA-3', with potential antineoplastic activity. Trebedersen binds to TGF-beta2 mRNA causing inhibition of protein translation, thereby decreasing TGF-beta2 protein levels; decreasing intratumoral TGF-beta2 levels may result in the inhibition of tumor cell growth and migration, and tumor angiogenesis. TGF-beta2, a cytokine often over-expressed in various malignancies, may play an important role in promoting the growth, progression, and migration of tumor cells.",fdaUniiCode:"98OYR854NY",identifier:"C80066",preferredName:a,semanticType:"Nucleic Acid, Nucleoside, or Nucleotide",subclassOf:["C1291"],synonyms:["AP 12009","TRABEDERSEN",a]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FTrabedersen",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Trabedersen","","2021-10-30T13:45:38.653Z")));